ANNX
Annexon, Inc.
Annexon, Inc. (ANNX) has 15 SEC Form 4 filings (15 transaction rows) in the rolling window, disclosed by 7 distinct insiders. Most recent filing: Jun 15, 2026.
The most active filer is Director Carson William H. with 3 filings. Insiders have net bought $3.3M over the trailing 6 months. The largest single insider purchase in this window was $3.3M by Director Satter Muneer A on May 28, 2026.
- Industry:Biotechnology
- CEO:Douglas E. Love
- Employees:96
- HQ:Brisbane, CA, US
- IPO:2020-07-24
Insider Buying
$3.5M
reported purchases (SEC code P)
Insider Selling
$147K
reported sales (SEC code S)
Unique Insiders
7
in the rolling window
Market Cap
$1.0B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
Satter Muneer AFirst filing | Director | Purchase | 613,497 | $3.3M | May 29 | SEC ↗ |
| Director | Purchase | 8,000 | $46K | May 13 | SEC ↗ | |
| Director | Purchase | 8,000 | $50K | Apr 14 | SEC ↗ | |
Carson William H.First filing | Director | Purchase | 8,000 | $45K | Mar 12 | SEC ↗ |
Lew JenniferFirst filing | EVP & CHIEF FINANCIAL OFFICER | Sale | 5,565 | $30K | Mar 4 | SEC ↗ |
ARTIS DEAN RICHARDFirst filing | EVP & CHIEF SCIENTIFIC OFFICER | Sale | 5,894 | $32K | Mar 4 | SEC ↗ |
Dananberg JamieFirst filing | CHIEF MEDICAL OFFICER | Sale | 5,820 | $32K | Mar 4 | SEC ↗ |
Overdorf MichaelFirst filing | EVP & CHIEF BUSINESS OFFICER | Sale | 4,339 | $24K | Mar 4 | SEC ↗ |
Yednock TedFirst filing | EVP & CHIEF INNOVATION OFFICER | Sale | 5,566 | $30K | Mar 4 | SEC ↗ |
Related companies
Annexon, Inc. is in the Healthcare sector.